63 related articles for article (PubMed ID: 31975504)
21. MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL.
Liang G; Ling Y; Lin Q; Shi Y; Luo Q; Cen Y; Mehrpour M; Hamai A; Li J; Gong C
Front Cell Dev Biol; 2021; 9():707049. PubMed ID: 34395434
[TBL] [Abstract][Full Text] [Related]
22. Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway.
Li M; Shan W; Hua Y; Chao F; Cui Y; Lv L; Dou X; Bian X; Zou J; Li H; Lin W
Front Cell Dev Biol; 2021; 9():661602. PubMed ID: 34136482
[TBL] [Abstract][Full Text] [Related]
23. A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.
Yang L; Zou X; Zou J; Zhang G
Med Sci Monit; 2021 May; 27():e930639. PubMed ID: 33963171
[TBL] [Abstract][Full Text] [Related]
24. Role of TSC1 in physiology and diseases.
Mallela K; Kumar A
Mol Cell Biochem; 2021 Jun; 476(6):2269-2282. PubMed ID: 33575875
[TBL] [Abstract][Full Text] [Related]
25. MiR-92b-3p inhibits proliferation and migration of C2C12 cells.
Ye Z; Shi J; Ning Z; Hou L; Hu CY; Wang C
Cell Cycle; 2020 Nov; 19(21):2906-2917. PubMed ID: 33043788
[TBL] [Abstract][Full Text] [Related]
26. miRNA-223 at the crossroads of inflammation and cancer.
Jeffries J; Zhou W; Hsu AY; Deng Q
Cancer Lett; 2019 Jun; 451():136-141. PubMed ID: 30878527
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
Wang C; Uemura M; Tomiyama E; Matsushita M; Koh Y; Nakano K; Hayashi Y; Ishizuya Y; Jingushi K; Kato T; Hatano K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Tsujikawa K; Nonomura N
Cancer Sci; 2020 Apr; 111(4):1146-1155. PubMed ID: 31975504
[TBL] [Abstract][Full Text] [Related]
28. miR-92b-3p-TSC1 axis is critical for mTOR signaling-mediated vascular smooth muscle cell proliferation induced by hypoxia.
Lee J; Heo J; Kang H
Cell Death Differ; 2019 Sep; 26(9):1782-1795. PubMed ID: 30518907
[TBL] [Abstract][Full Text] [Related]
29. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
[TBL] [Abstract][Full Text] [Related]
30. microRNA 92b-3p regulates primordial follicle assembly by targeting TSC1 in neonatal mouse ovaries.
Li T; Liu X; Gong X; E Q; Zhang X; Zhang X
Cell Cycle; 2019 Apr; 18(8):824-833. PubMed ID: 30880550
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
32. High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin.
Jingushi K; Kashiwagi Y; Ueda Y; Kitae K; Hase H; Nakata W; Fujita K; Uemura M; Nonomura N; Tsujikawa K
Int J Oncol; 2017 Jul; 51(1):289-297. PubMed ID: 28534944
[TBL] [Abstract][Full Text] [Related]
33. mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma.
Drusian L; Nigro EA; Mannella V; Pagliarini R; Pema M; Costa ASH; Benigni F; Larcher A; Chiaravalli M; Gaude E; Montorsi F; Capitanio U; Musco G; Frezza C; Boletta A
Cell Rep; 2018 Jul; 24(5):1093-1104.e6. PubMed ID: 30067967
[TBL] [Abstract][Full Text] [Related]
34. miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo.
Gong L; Ren M; Lv Z; Yang Y; Wang Z
DNA Cell Biol; 2018 May; 37(5):501-511. PubMed ID: 29638162
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-183 promotes the proliferation and metastasis of renal cell carcinoma through targeting Dickkopf-related protein 3.
Zhang XL; Xu G; Zhou Y; Yan JJ
Oncol Lett; 2018 Apr; 15(4):6003-6008. PubMed ID: 29552228
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
